Mitochon Pharmaceuticals, Inc.

Blue Bell, PA

UEI
JGJ7TELAKUY8
CAGE
7NNV1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Hispanic American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
970 Cross Ln, Blue Bell, PA 19422, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $50,000

Contract awards

Award Agency Obligated Awarded
MP201 drug development/synthesis HT942525P0014 Defense Health Agency $50,000

Quick answers

Is Mitochon Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Mitochon Pharmaceuticals, Inc.'s SAM.gov registration is active through August 5, 2027.

How much has Mitochon Pharmaceuticals, Inc. received in federal contracts?

Federal contracts obligated $50,000 to Mitochon Pharmaceuticals, Inc. in fiscal year 2025.

How does Mitochon Pharmaceuticals, Inc. rank among federal contractors?

Mitochon Pharmaceuticals, Inc. ranked #24 in PSC AN14 in FY2025.

What is Mitochon Pharmaceuticals, Inc.'s most recent federal award?

Mitochon Pharmaceuticals, Inc.'s most recent federal contract award is MP201 drug development/synthesis (HT942525P0014), from Defense Health Agency, on November 8, 2024.

On GovTribe

See Mitochon Pharmaceuticals, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors